CIK 0000946644 · Non-accelerated filer<br>Smaller reporting company
AIM ImmunoTech Inc.
Sign in to watch- Ticker
- AIM
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 520845822
- Phone
- 352-448-7797
- Business address
- 2117 SW HIGHWAY 484, OCALA, FL, 32801
- Former names
- AIM ImmunoTech Inc., HEMISPHERX BIOPHARMA INC
- 10-Q Report Quarterly Report
- DEFA14A Proxy Proxy Materials
- 8-K Event Regulation FD disclosure
- DEFA14A Proxy Proxy Materials
- DEFC14A Other DEFC14A
- DEFC14A Other DEFC14A
- CORRESP Other Correspondence Between Filers and SEC Staff
- PRER14A Other PRER14A
- UPLOAD Other SEC-generated Letter
- UPLOAD Other SEC-generated Letter
- PREC14A Other PREC14A
- PREC14A Other PREC14A
- 4 Open-market buy CEO & President bought 22,676 shares at $0.44 ($10,000)
- 8-K Event Material agreement
- 8-K Event Regulation FD disclosure
- DFAN14A Other Proxy Soliciting Materials
- SC 13D/A Stake Beneficial Ownership Report
- 4 Open-market buy CEO & President bought 8,222 shares at $0.67 ($5,501)
- 4 Open-market buy CEO & President bought 14,993 shares at $0.67 ($10,000)
- DEFA14A Proxy Proxy Materials
Page 15 of 82 · 1,637 filings